Health & Safety Industry Today

Pet Therapeutic Diet Market to Hit USD 7.47 Billion by 2032 as Preventive Pet Health and Personalized Nutrition Surge

The pet therapeutic diet market is expanding rapidly, driven by rising preventive pet healthcare and growing demand for personalized, condition-specific nutrition. Increased veterinary guidance and a significant rise in chronic diseases among pets continue to boost global adoption.
Published 11 December 2025

Pet Therapeutic Diet Market Report Scope & Overview

The pet therapeutic diet market is witnessing strong global expansion as pet owners increasingly adopt preventive healthcare and specialized nutrition to manage chronic pet diseases. Valued at USD 4.20 billion in 2024, the market is projected to reach USD 7.47 billion by 2032, advancing at a 7.48% CAGR over 2025–2032. The sustained rise in chronic conditions such as obesity, renal disorders, and digestion-related ailments in pets is significantly reshaping purchasing patterns, with owners opting for scientifically formulated therapeutic diets recommended by veterinarians. The shift toward “pet parenting,” coupled with technology-enabled veterinary care, continues to elevate demand for personalized nutrition, further strengthening pet therapeutic diet market growth.

Growing awareness of obesity in pets is a major catalyst for demand expansion. In the U.S. alone, more than 60% of dogs and 55% of cats were recorded obese in 2024, triggering a 19% increase in therapeutic weight-management diet sales. Veterinary practices play a pivotal role, with over 68% of chronic disease consultations in the U.S. leading to therapeutic diet recommendations. As more pet owners rely on clinical nutrition guidance and tele-advice, the pet therapeutic diet market is turning into a cornerstone of modern companion animal healthcare.

Explore Key Trends in the Market: Request Your Sample Report: https://www.snsinsider.com/sample-request/8376

Nutrition Becomes the Central Driver of Long-Term Pet Wellness

Nutrition remains the strongest driver fueling the pet therapeutic diet market. As preventive care becomes mainstream, therapeutic diets designed for immunity improvement, weight control, allergy management, renal support, and digestive enhancement are gaining widespread traction. According to APPA, nearly 72% of U.S. pet owners choose therapeutic diets for chronic conditions, reflecting a major shift from general pet foods to targeted medical nutrition. Personalized dietary solutions that address obesity, allergies, and digestive complications form a critical part of this transition, positioning the market for robust, long-term expansion.

Homemade Diets Continue to Challenge Market Penetration

Despite growth momentum, the market faces resistance from pet owners inclined toward homemade diets, believing them to be more natural and healthier. However, studies show that nearly 60% of homemade diets are nutritionally inadequate, posing long-term health risks. Yet the preference persists due to misinformation, ingredient control preferences, and mistrust of commercial products. This trend slows market adoption, particularly in categories requiring condition-specific precision, such as renal care or weight management. As veterinary associations continue to educate consumers, the gap between scientifically formulated therapeutic diets and homemade regimens is expected to narrow.

Dry Food Leads Product Adoption with Proven Clinical Benefits

Dry food emerged as the dominant and fastest-growing category, holding 65.26% of the market in 2024. Its longer shelf life, ease of storage, cost-effectiveness, and clinical formulation accuracy make it highly suitable for therapeutic purposes, particularly for obesity, renal care, and diabetes. Veterinarians also favor dry kibble for its dental health benefits and consistent nutrient profile. Broad retail availability and strong penetration across veterinary hospitals further reinforce its market leadership.

Dogs Lead Consumption, While Cats Become Fastest-Growing Segment

Dogs accounted for 62.80% of the global market in 2024, supported by high dog ownership rates and rising incidences of canine-specific conditions such as joint problems, obesity, skin disorders, and kidney disease. Strong veterinary endorsement and emotional bonding between dog owners and their pets fuel the higher compliance for therapeutic diets.

Cats, however, are projected to witness the fastest growth, with an 8.01% CAGR over the forecast period. Increased awareness of feline renal conditions, urinary tract disorders, and nutrient-specific feeding plans is driving adoption. With cat ownership rising significantly across urban households, demand for tailored dietary formulations is set to accelerate.

Obesity Care Dominates, While Renal Care Shows Fastest Growth

Obesity care accounts for 20.89% of the overall market, driven by the alarming rise in overweight pets globally. Weight-management therapeutic diets are now central to preventing complications such as diabetes, joint pain, and cardiac conditions.

Meanwhile, renal care is emerging as the fastest-growing segment with an 8.16% CAGR, propelled by the strong prevalence of chronic kidney disease (CKD) in aging pets. Improved diagnostics, wider veterinary support, and increased public awareness underpin the rise in renal-specific diets.

Veterinary Hospitals Lead Distribution, E-Commerce Witnesses Surge

Veterinary hospitals and clinics remain the most influential distribution channel, supported by professional dietary prescriptions, higher owner trust, and better compliance rates. These facilities continue to drive adoption by providing tailored nutrition plans for chronic conditions.

E-commerce is experiencing accelerated growth as pet owners shift toward digital purchasing for convenience, subscription-based auto-replenishment, and access to a wider portfolio of veterinary-approved products. Online retail is transforming long-term diet adherence by simplifying repeat purchases and offering competitive pricing.

Interest in Market Trends: Get Detailed Analysis and Insights with Our Comprehensive Report: https://www.snsinsider.com/reports/pet-therapeutic-diet-market-8376

North America Leads, Asia-Pacific Becomes the Growth Hotspot

North America held 41.60% of the global market in 2024 owing to high pet ownership, strong veterinary infrastructure, and increased awareness of chronic pet conditions. Europe remains the second-largest region as pet owners invest more in specialty diets, veterinary consultations, and premium pet food.

Asia-Pacific is the fastest-growing region with an 8.28% CAGR driven by rising disposable incomes, rapid urbanization, and expanding pet adoption in China, India, Japan, and South Korea. Western-influenced pet care trends, growing e-commerce penetration, and government-backed animal welfare initiatives are accelerating market maturity.

Key Companies Continue Strategic Innovation and Launches

Leading companies such as Hill’s Pet Nutrition, Royal Canin, Purina Pro Plan Veterinary Diets, Blue Buffalo, Farmina Vet Life, Virbac, Dechra, Nom Nom, and others are expanding therapeutic portfolios and investing in research-backed nutritional solutions. Recent innovations include Hill’s Prescription Diet Derm Complete targeting chronic skin issues, Blue Buffalo’s reformulated GI support diet, and Virbac’s enhanced obesity management formula.

Other Trending Reports

Catheters Market

Geriatric Medicine Market

MRNA Therapeutics Contract Development & Manufacturing Market

Womens Wearable Fertility Monitors Market

Other Industry News

Ready to start publishing

Sign Up today!